CASE 1
Patient 1 was a 23 year old male with peripheral T-cell lymphoma not
otherwise specified (PTCL-NOS) who received six cycles of
cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone
(CHOEP) with complete metabolic response (CR1). He was referred for high
dose chemotherapy with autologous peripheral blood stem cell transplant.
Restaging PET and CT showed no evidence of disease but was notable for
incidental findings of dilated and enhanced appendix (Figure 1). The
patient was asymptomatic with benign physical exam and laboratory data
was unremarkable. This prompted surgical evaluation which resulted in
immediate preemptive laparoscopic appendectomy. Resulting pathology
revealed a mucinous adenoma without high grade dysplasia and margins
uninvolved by tumor. Transplant was postponed for 5 weeks to allow for
adequate recovery. The patient went on to receive a conditioning regimen
of carmustine (BCNU), etoposide, cytarabine and melphalan (BEAM)
followed by autologous stem cell transplant without any complications.